Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.

Tham E, Grandell U, Lindgren E, Toss G, Skogseid B, Nordenskjöld M.

J Clin Endocrinol Metab. 2007 Sep;92(9):3389-95. Epub 2007 Jul 10.

PMID:
17623761
2.
3.

A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.

Raef H, Zou M, Baitei EY, Al-Rijjal RA, Kaya N, Al-Hamed M, Monies D, Abu-Dheim NN, Al-Hindi H, Al-Ghamdi MH, Meyer BF, Shi Y.

Clin Endocrinol (Oxf). 2011 Dec;75(6):791-800. doi: 10.1111/j.1365-2265.2011.04134.x.

PMID:
21627674
4.

Multiple endocrine neoplasia type 1.

Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, Brandi ML.

Orphanet J Rare Dis. 2006 Oct 2;1:38. Review.

5.

Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1.

Owens M, Ellard S, Vaidya B.

Clin Endocrinol (Oxf). 2008 Mar;68(3):350-4. Epub 2007 Sep 14.

PMID:
17854391
6.

Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop).

Valdés N, Pérez de Nanclares G, Alvarez V, Castaño L, Díaz-Cadórniga F, Aller J, Coto E.

Clin Endocrinol (Oxf). 1999 Mar;50(3):309-13.

PMID:
10435055
7.

Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.

Uchino S, Noguchi S, Nagatomo M, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Wakiya S, Adachi M.

Biomed Pharmacother. 2000 Jun;54 Suppl 1:100s-103s.

PMID:
10915003
8.

Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1).

Hai N, Aoki N, Matsuda A, Mori T, Kosugi S.

Eur J Endocrinol. 1999 Nov;141(5):475-80.

9.

MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.

Balogh K, Hunyady L, Patocs A, Gergics P, Valkusz Z, Toth M, Racz K.

Clin Endocrinol (Oxf). 2007 Nov;67(5):727-34.

PMID:
17953629
10.

Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.

Klein RD, Salih S, Bessoni J, Bale AE.

Genet Med. 2005 Feb;7(2):131-8.

PMID:
15714081
11.

Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.

Uchino S, Noguchi S, Sato M, Yamashita H, Yamashita H, Watanabe S, Murakami T, Toda M, Ohshima A, Futata T, Mizukoshi T, Koike E, Takatsu K, Terao K, Wakiya S, Nagatomo M, Adachi M.

Cancer Res. 2000 Oct 1;60(19):5553-7.

12.

MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.

Corbo V, Dalai I, Scardoni M, Barbi S, Beghelli S, Bersani S, Albarello L, Doglioni C, Schott C, Capelli P, Chilosi M, Boninsegna L, Becker KF, Falconi M, Scarpa A.

Endocr Relat Cancer. 2010 Aug 16;17(3):771-83. doi: 10.1677/ERC-10-0028. Print 2010 Sep.

13.

Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.

Goebel SU, Heppner C, Burns AL, Marx SJ, Spiegel AM, Zhuang Z, Lubensky IA, Gibril F, Jensen RT, Serrano J.

J Clin Endocrinol Metab. 2000 Jan;85(1):116-23.

PMID:
10634374
14.

Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.

Haven CJ, van Puijenbroek M, Tan MH, Teh BT, Fleuren GJ, van Wezel T, Morreau H.

Clin Endocrinol (Oxf). 2007 Sep;67(3):370-6. Epub 2007 Jun 6.

PMID:
17555500
15.

Multiple endocrine neoplasia type 1 (MEN1) in Austria.

Weinhäusel A, Kaserer K, Vierhapper H, Niederle B, Haas OA; Study Group of Multiple Endocrine Neoplasia Austria.

Wien Klin Wochenschr. 2002 Apr 15;114(7):252-7.

PMID:
12089860
16.

The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.

Ozawa A, Agarwal SK, Mateo CM, Burns AL, Rice TS, Kennedy PA, Quigley CM, Simonds WF, Weinstein LS, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ.

J Clin Endocrinol Metab. 2007 May;92(5):1948-51. Epub 2007 Feb 13.

PMID:
17299066
17.

Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).

Turner JJ, Christie PT, Pearce SH, Turnpenny PD, Thakker RV.

Hum Mutat. 2010 Jan;31(1):E1089-101. doi: 10.1002/humu.21170.

PMID:
19953642
18.

Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).

Gaztambide S, Vazquez F, Castaño L.

Minerva Endocrinol. 2013 Mar;38(1):17-28. Review.

PMID:
23435440
19.

MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.

Alvelos MI, Vinagre J, Fonseca E, Barbosa E, Teixeira-Gomes J, Sobrinho-Simões M, Soares P.

Eur J Endocrinol. 2012 Dec 31;168(2):119-28. doi: 10.1530/EJE-12-0327. Print 2013 Feb.

20.

MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.

Jiang XH, Lu JL, Cui B, Zhao YJ, Wang WQ, Liu JM, Fang WQ, Cao YN, Ge Y, Zhang CX, Casse H, Li XY, Ning G.

Endocr Relat Cancer. 2007 Dec;14(4):1073-9.

Supplemental Content

Support Center